Surgery without radiotherapy for primary treatment of endometrial cancer

OBJECTIVE: To analyze the role of surgery alone, including pelvic and para-aortic lymphadenectomy, in patients with endometrial cancer who did not receive radiotherapy. METHODS: Between August 1987 and January 1997, 225 women with disease clinically confined to the uterus were staged surgically by a standard protocol that included pelvic and para-aortic lymphadenectomy in women with high risk factors. No radiation was administered before or after surgery. RESULTS: The combination of preoperative endometrial biopsy grade and gross depth of myometrial invasion identified 123 (55%) high-risk patients who had lymphadenectomy and 102 (45%) low-risk patients who did not. Eighteen (15%) high-risk patients had lymph node metastases and received postoperative systemic therapy. Three low-risk, eight high-risk-node-negative, and no high-risk-node-positive patients were diagnosed with recurrent cancer, corresponding to 5-year recurrence-free proportions of 0.95, 0.89, and 1.00, respectively. Although sample sizes and limited follow-up limit conclusions, the experience to date suggests a high rate of survival in all three groups. CONCLUSION: Our preliminary experience indicates that even high-risk patients have an excellent prognosis when treated with surgery, including pelvic and para-aortic lymphadenectomy, without radiotherapy.

This article has been cited by other articles:

				I. Ben-Shachar, J. Pavelka, D. E. Cohn, L. J. Copeland, N. Ramirez, T. Manolitsas, and J. M. Fowler Surgical Staging for Patients Presenting With Grade 1 Endometrial Carcinoma Obstet. Gynecol., March 1, 2005; 105(3): 487 - 493. [Abstract] [Full Text] [PDF]

				B. DuBeshter, C. Deuel, S. Gillis, C. Glantz, C. Angel, and D. Guzick Endometrial Cancer: The Potential Role of Cervical Cytology in Current Surgical Staging Obstet. Gynecol., March 1, 2003; 101(3): 445 - 450. [Abstract] [Full Text] [PDF]